Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Yun HJ; KCSG TRIUMPH Investigators. Keam B, et al. Among authors: hong mh. J Clin Oncol. 2024 Feb 10;42(5):507-517. doi: 10.1200/JCO.22.02786. Epub 2023 Sep 12. J Clin Oncol. 2024. PMID: 37699162 Clinical Trial.
Prognosis of pN3 stage gastric cancer.
Ahn JR, Jung M, Kim C, Hong MH, Chon HJ, Kim HR, Jeung HC, Hyung WJ, Lee SS, Chung HC, Noh SH, Rha SY. Ahn JR, et al. Among authors: hong mh. Cancer Res Treat. 2009 Jun;41(2):73-9. doi: 10.4143/crt.2009.41.2.73. Epub 2009 Jun 30. Cancer Res Treat. 2009. PMID: 19707504 Free PMC article.
Clinical value of ezrin expression in primary osteosarcoma.
Kim C, Shin E, Hong S, Chon HJ, Kim HR, Ahn JR, Hong MH, Yang WI, Roh JK, Rha SY. Kim C, et al. Among authors: hong s, hong mh. Cancer Res Treat. 2009 Sep;41(3):138-44. doi: 10.4143/crt.2009.41.3.138. Epub 2009 Sep 28. Cancer Res Treat. 2009. PMID: 19809563 Free PMC article.
Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis.
Kim CG, Shim HS, Hong MH, Cha YJ, Heo SJ, Park HS, Kim JH, Lee JG, Lee CY, Cho BC, Kim HR. Kim CG, et al. Among authors: hong mh. Oncotarget. 2017 May 10;8(39):65111-65122. doi: 10.18632/oncotarget.17786. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029416 Free PMC article.
464 results